Total raised: $150M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.08.2024 | Series A | $150M | - |
Mentions in press and media 2
| Date | Title | Description |
| 22.08.2024 | Borealis Biosciences Raises $150M in Series A Funding | Borealis Biosciences, a Vancouver, BC-based RNA medicines company, raised $150M in Series A funding. The round was led by Versant Ventures and Novartis AG. The company intends to use the funds to expand operations and its development effort... |
| - | Borealis Biosciences | “Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant... |